Mohamed Elati



institut de Biologie Systémique et Synthétique (iSSB)
Genopole Campus 1, Genavenir 6
5 rue Henri Desbruères
91030 EVRY Cedex

+33 (0)1 69 47 44 43

+33(0)1 69 47 44 37


2004-2007 : PhD in Computer Science, Université Paris-Nord. I passed my PhD in between Machine Learning (LIPN, Université Paris-Nord Villetaneuse), Bioinformatics  (LRI, Université Paris-Sud Orsay) and  Molecular Biology (Institut Curie, Paris).

Research Areas

Systems Biology  - Machine Learning   -  Bioinformatics

  •  The major focus of our research is the inference and interrogation of biological networks, guided by large-scale  high-dimensional data from genomics and genetic experiments. Our methodological research aims to develop and improve computational and statistical methods in data mining, multi-view learning, and multi-objective optimization to:    
  1. The reverse engineering of gene regulatory networks
  2. The identification of cis-regulatory elements
  3. The study of the influence of spatial organization of genome on gene expression
  4. The identification of master regulators controlling the transition between to phenotypes
  5. The extraction of protein complexes and functional modules
  • I’m involved as principal investigator (PI) for iSSB-UEVE in the following projects :  
    1. 2016-18:  Large-scale Integrative approach to unravel the complex relationships between differentiatiON and tumorigenesiS - LIONS - INSERM/ITMO cancer - Coordinator Dr. Mohamed Elati
    2. 2015-18: Adaptive Automated Scientifc Laboratory - AdaLab  -  CHIST-ERA (ANR) - Coordinator Dr. Larisa Soldatova
    3. 2013-15: A system biology approch to dissect cilia function and its disruption in human genetic disease - SYSCILIA (EC FP7 - Health Cooperation programme) - Coordinator Dr. Ronald Roepman
    4.  2013-14: Comparaison de Réseaux de régulation par Enumération de PErturbations - CREPE (PEPS CNRS) - Coordinator Prof. Etienne Birmelé
    5.   2011-13: Search for new therapeutic targets through the Identification of networks specifically altered in cancer - INSIGht (INCa) – Coordinator Dr. François Radvanyi